Delivery Order SPE2DR25D2009-SPE2DR26FJ4E6
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,089.08. The contract is firm fixed price with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025, with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order for Rifampin 300 mg capsules (60-count) valued at $2,852.92 by the Defense Logistics Agency on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed pricing and was competitively awarded without set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,232.41 to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order from the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,763.68. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, operates under firm fixed-price terms with no set-aside designation and represents a competitive award. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,136.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Rifampin 300 mg capsules (60-count units). The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 18, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.80 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count packaging) on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,200.66 by the Defense Logistics Agency for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-competitive contract awarded on August 26, 2025, with a completion date of August 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4E6Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,528.39 by the Defense Logistics Agency (DLA) on December 12, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be completed by December 15, 2025, with fulfillment occurring at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026. The IDC serves as a flexible procurement mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Rifampin, an antibiotic used primarily in treating tuberculosis and certain mycobacterial infections, represents one of the critical medical commodities delivered under this overarching contract vehicle to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 12/11/25 |